Sign in
4

Changes in Ownership

Monopar Therapeutics Filed Acc 0001437749-23-019257

Chief Executive Officer gave up 10,269 shares (to pay taxes)

  • Chief Executive Officer acquired 35,039 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Robinson Chandler Chief Executive Officer 2023-06-30 Option exercise +35,039 121,393.8 D
Robinson Chandler Chief Executive Officer 2023-06-30 Shares withheld for taxes −10,269 $0.86 $8,780 111,124.8 D
Derivatives
Robinson Chandler Chief Executive Officer 2023-06-30 Option exercise · Restricted Stock Units −35,039 277,957 D
Loading xslF345X04/rdgdoc.xml…